Medindia
Medindia LOGIN REGISTER
Advertisement

Dyadic International Reports 2010 Second Quarter Financial Results

Friday, August 13, 2010 Corporate News
Advertisement

DYADIC INTERNATIONAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Six Months Ended June 30,

2010

2009

(Unaudited)

(Unaudited)

Operating Activities

Net Income (Loss)

$

(2,521,193)

$

10,891,584

Adjustments to Reconcile Net Income (Loss) to Net Cash               Provided By (Used In) Operating Activities:

Depreciation and Amortization of Fixed Assets

151,096

87,682

Amortization of Intangible and Other Assets

7,068

7,067

Reduction of Allowance for Doubtful Accounts

(132,030)

-

Reduction of Inventory Reserve

(333,795)

(490,414)

Compensation Expense on Stock Option Grants

425,032

58,025

Stock Issued for Financial Services

63,000

-

Stock Issued for Rent

-

5,000

Gain on Reduction of Accrued Stockholder Litigation

(410,000)

-

Changes in Operating Assets and Liabilities:

Accounts Receivable

(118,717)

(9,247)

Inventory

399,751

1,125,490

Prepaid Expenses and Other Current Assets

117,787

22,105

Other Assets

-

27,604

Accounts Payable

(66,234)

(319,621)

Accrued Expenses

(434,030)

(74,011)

Accrued Interest Payable to Stockholder

(26,088)

(167,154)

Accrued Stockholder Litigation

(1,500,000)

-

Deferred Research and Development Obligations

-

(3,082,863)

Income Taxes Payable

1,238

(5,584)

Net Cash Provided By (Used In) Operating Activities

(4,377,115)

8,075,663

Investing Activities

Purchases of Fixed Assets

(157,315)

(12,402)

Patent Costs

(6,284)

-

Restricted Cash

45,589

1,197

Net Cash (Used In) Investing Activities

(118,010)

(11,205)

Financing Activities

Repayment of Note Payable to Stockholder

-

(1,000,000)

Proceeds from Stock Warrant Exercises

16,876

-

Proceeds from Stock Option Exercises

22,801

-

Net Cash Provided By (Used In) Financing Activities

39,677

(1,000,000)

Net Increase (Decrease) in Cash and Cash Equivalents

(4,455,448)

7,064,458

Cash and Cash Equivalents at Beginning of Period

8,419,934

2,826,542

Cash and Cash Equivalents at End of Period

$

3,964,486

$

9,891,000

Supplemental Cash Flow Information:

Cash Paid for Interest

$

91,154

$

277,020

Sponsored Post and Backlink Submission


Latest Press Release on Corporate News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close